+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 45Years
FEMALE
Healthy Volunteers
ID07140640

Reducing Hyperbaric Bupivacaine Dose to Prevent High Spinal Block in Cesarean Delivery A Randomized, Double-Blind Study with Risk-Stratification

Led by Aswan University · Updated on 2026-08-26

666

Participants Needed

1

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

This research evaluates the impact of reducing the dose of intrathecal hyperbaric bupivacaine by 20% on the occurrence of high spinal block in women undergoing cesarean delivery. The trial is a prospective, randomized, double-blind, active-controlled study conducted in a single academic hospital setting. Participants are stratified by risk using a 7-factor model before randomization to better understand how well dose-aware versus dose-blind scoring predicts spinal block risk. Participants are randomly assigned to one of two groups the reduced-dose group receives 10 mg of hyperbaric bupivacaine combined with 25 mcg fentanyl, while the standard-dose group receives 12.5 mg of hyperbaric bupivacaine plus 25 mcg fentanyl. The spinal anesthesia is administered via a lumbar puncture with careful technique and positioning. Hemodynamic monitoring and safety protocols are followed during surgery without routine vasopressor use to avoid affecting the primary outcome. During the study, participants are closely monitored for sensory and motor block levels, heart rate, oxygen saturation, and blood pressure at frequent intervals up to surgery completion. Researchers assess the incidence of high spinal block within 15 minutes after drug administration as the primary outcome. Secondary outcomes include the accuracy of the risk prediction score, neonatal health shortly after birth, maternal satisfaction hours after surgery, and intraoperative hemodynamic stability. Total participation involves the surgery and immediate recovery period, with data collected up to about 2 hours post-anesthesia.

CONDITIONS

Brief Title

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery

Research Team

E

Eman Mahmoud Ismail, Resident

S

Soudy Salah Hammad, consultant

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here